ICCC
Price
$6.61
Change
-$0.15 (-2.22%)
Updated
Jul 25 closing price
Capitalization
59.74M
19 days until earnings call
JANX
Price
$25.96
Change
-$0.01 (-0.04%)
Updated
Jul 25 closing price
Capitalization
1.54B
17 days until earnings call
Interact to see
Advertisement

ICCC vs JANX

Header iconICCC vs JANX Comparison
Open Charts ICCC vs JANXBanner chart's image
ImmuCell
Price$6.61
Change-$0.15 (-2.22%)
Volume$9.91K
Capitalization59.74M
Janux Therapeutics
Price$25.96
Change-$0.01 (-0.04%)
Volume$1.32M
Capitalization1.54B
ICCC vs JANX Comparison Chart in %
Loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICCC vs. JANX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCC is a Hold and JANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ICCC: $6.61 vs. JANX: $25.96)
Brand notoriety: ICCC and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICCC: 34% vs. JANX: 174%
Market capitalization -- ICCC: $59.74M vs. JANX: $1.54B
ICCC [@Biotechnology] is valued at $59.74M. JANX’s [@Biotechnology] market capitalization is $1.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCC’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • ICCC’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, ICCC is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCC’s TA Score shows that 5 TA indicator(s) are bullish while JANX’s TA Score has 6 bullish TA indicator(s).

  • ICCC’s TA Score: 5 bullish, 3 bearish.
  • JANX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ICCC and JANX are a good buy in the short-term.

Price Growth

ICCC (@Biotechnology) experienced а -0.15% price change this week, while JANX (@Biotechnology) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ICCC is expected to report earnings on Aug 14, 2025.

JANX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.54B) has a higher market cap than ICCC($59.7M). ICCC YTD gains are higher at: 28.350 vs. JANX (-51.513). ICCC has higher annual earnings (EBITDA): 2.94M vs. JANX (-111.54M). JANX has more cash in the bank: 1.01B vs. ICCC (4.6M). ICCC has less debt than JANX: ICCC (14.7M) vs JANX (22.6M). ICCC has higher revenues than JANX: ICCC (27.3M) vs JANX (9.34M).
ICCCJANXICCC / JANX
Capitalization59.7M1.54B4%
EBITDA2.94M-111.54M-3%
Gain YTD28.350-51.513-55%
P/E RatioN/AN/A-
Revenue27.3M9.34M292%
Total Cash4.6M1.01B0%
Total Debt14.7M22.6M65%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICCCJANX
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 16 days ago
77%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEIQX41.88N/A
N/A
Principal Equity Income R5
FGHMX122.39N/A
N/A
Fidelity Advisor Communication ServicesC
NREEX14.00N/A
N/A
Neuberger Berman Real Estate E
VIOAX9.82N/A
N/A
VELA Income Opportunities A
PMICX10.93N/A
N/A
Putnam Multi-Asset Income C

ICCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCC has been loosely correlated with NKTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ICCC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
-4.89%
NKTX - ICCC
43%
Loosely correlated
+0.93%
BOLT - ICCC
26%
Poorly correlated
-4.24%
TRAW - ICCC
24%
Poorly correlated
-3.07%
CTNM - ICCC
24%
Poorly correlated
+1.23%
JANX - ICCC
24%
Poorly correlated
-0.04%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with SKYE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-0.04%
SKYE - JANX
41%
Loosely correlated
-2.49%
CRNX - JANX
39%
Loosely correlated
+1.91%
IDYA - JANX
38%
Loosely correlated
-1.33%
SYRE - JANX
37%
Loosely correlated
+1.08%
TERN - JANX
37%
Loosely correlated
-0.17%
More